Ketamine has been shown to exert antidepressant-like effects in different animal models of depression by activation of the mammalian target of rapamycin (mTOR), by increasing the expression of synaptic proteins and increasing synaptogenesis in the prefrontal cortex [62]. This evidence concerns the gene MTOR and depressive symptom measurement.